6-øglucose-6-phosphate  dehydrogenase
absolute lethal  dose
acetylcholinesteraseø
acetylcholine
activation
activator
addition
additive  effectۼЧӦ
additiveӼ
adjuvant
aerogel
aerosolܽ
alkali-poisoningж
alkaloid
alkalosisж
allergic  reaction̬Ӧ
allergy̬Ӧ
anaphylatoxin
anatoxin඾
antagonism׿
antibody
antigenԭ
antipodeӳ
antiserumѪ
antitoxin
aqua  regiaˮ
astringentҩ
autoimmunity
bacteriophageɾ
bactriostasis־
Becquerelն
bioavailabilityö
biochemistryﻯѧ
biometricsͳѧ
biometryͳѧ
biopharmacyҩѧ
carcinogen°
carrier
catecholamineӰ
chemotherapyѧҩ
cholinesteraseø
chronaxiaʱֵ
chronaxyʱֵ
chronic toxicity  testԶʵ
chronopharmacologyʱҩѧ
chronosusceptabilityʱ
chronotherapyʱ
coenzymeø
cold-storage
complement
concentrationŨ
crude  drugsҩȻҩ
date of  expirationҩƷЧ
desiccant
detoxicationⶾ
dextrose
diffusionɢ
disintegrants
disintegration
dissolutionܽ
dissolventܼ
dissolvingܽ
dosage
dose
drying  agent
EDOü
effectorЧӦЧӦ
effectЧӦ
electrolyte
electrolyzation
endotoxinڶ
enzymeø
ethnopharmacologyҩѧ
excipients
excitability˷
exotoxinⶾ
expiry  dateҩƷЧ
fatal  dose
fermentation
film-coatingĤ
filtration
freezing䶳
gene
gluconeogenesis
glycolysisͽ
gram-atomԭ
gram-molecule˷
gram-mol˷
half lethal  dose
half life  time˥
half-life  period˥
halogenide±
haptene뿹ԭ
hemolysisѪ
histamine鰷
hormone
hydrolysisˮ⣨ã
hyperreactivity
immuno  inhibitorƼ
immunoenhancementǿ
immunogenicityԭ
immunosuppressantƼ
implantsֲ
individual  differences
individual  variation
inhalation뷨
intermediateм
intoxicationж
isomerase칹ø
isotopeͬλ
Janbonۺ֢Janbon''s  syndrome
LD100
LD50
LDOܼ
lethal  dose
levulose
liniments
liposome֬
long term toxicity  testڶʵ飻Զʵ
lysozymeܾø
macromolecule
materia  medicaҩѧ
maxial noneffective  doseü
maximal tolerable  doseܼ
median lethal  dose
mediator
medium
mesomer
minimal lethal  doseС
mixtureϼ
MLDС
molal  comcentration˷Ũ
molar  comcentratin˷Ũ
molar  volumeĦ
molarityĦŨ
mole  volumeĦ
moleĦ
mutationͻ
natural  drugsȻҩ
neurotoxin񾭶
nitrohydrochloric  acidˮ
nondepolarizerȥͼҩ
normalityŨ
nucleotide
nutrientӪ
oligosaccharides;
phagocytosis
pharmaceuticsҩѧ
pharmacodynamicsҩЧѧ
pharmacogeneticsҩŴѧ
pharmacologyҩѧҩѧ
pill
placeboο
plasmaѪ
plasterӲ
poisoningж
polyose
polypeptide
potencyЧۣЧǿ
PPBŨparts per billion  concentration
pphmŨparts per hundred million  concentration
PPHŨparts per hundred  concentration
ppmŨparts per million  concentration
preparationƼ
prescription
prodrugǰҩ
proenzymeøԭ
prohormoneԭ
raceme
radiopharmaceuticsҩѧ
radiotoxicology䶾ѧ
receptor
recipe
refrigeration䶳
ribonucleic  acidǺ
RNAǺ
saponins߰
selectivityѡ
sensitivity
sensitization
serumѪ
solute
solventܼ
subacute  intoxicationǼж
subacute  poisoningǼж
superinfectionظȾ
superoxide
suspensionҺ
synergismЭͬ
tachyphylaxis
TDMҩٲ
teratogen»
therapeutic drug  monitoringҩٲ
tincture
titrationζ
tolerance
toxic  reactionԷӦ
toxic  responseԷӦ
toxicologyѧ
toxoid඾
trace  elementԪأ΢Ԫ
transmitterʣ
WHO֯
World Health  Organization֯
ȫΧsafety  range
ȫ鷨innocuity test  method
ȫϵͳsafety  coefficient
οplacebo
ϼchelating  agent
ϸtarget  cell
׵΢Ƽalbumin  microballoons
ٷŨpercentage  concentration
ϳɿsemisynthetic  antibiotics
뿹ԭhaptene
half lethal dose ; median lethal dose;  LD50
˥half-life period; half life  time
Ƭcoated  tablet
Һsaturated  solution
նBecquerel
passive  immunity
תpassive  transport
disintegration
disintegrants
谱essential  aminoacid
֬essential fatty  acid
̬Ӧallergy; allergic  reaction
surface  activity
surface  tension
gamma  rays
Ĥfilm-coating
complement
ϵͳcomplement  system
Ӧadverse  reaction
ȫԭincomplete  antigen
liniments
ڶʵlong term toxicity  test
ЧƼprolonged action  preparation
ѭenterohepatic  circulation
ܿƬenteric controlled release  tablets
enteric  coating
prescription;recipe
͸ٽpenetration  enhancers
ԿƼmagnetic controlled release dosage  form
ҩƼmagnetic medicinal  preparations
macromolecule
¡monoclonal  antibody
øcholinesterase
equivalent  weight
equivalent  law
Ũnormality
Һnormal  solution
Һisotonic  solution
;oligosaccharides
ܶ֬low density  lipoprotein
ζtitration
ζtitration  curve
pill
transmitter
electrolyzation
electrolyte
ѧdispensing  pharmacy
tincture
ҩƼdirected pharmaceutical  preparations
ѧtoxicology
ԷӦtoxic response; toxic  reaction
°ʵshort term carcinogenic  test
etiological  treatment
ӳantipode
֢symptomatic  treatment
๦ømultifunctional  enzyme
ҩmultiple dose  administration
polypeptide
polyose
Ӱcatecholamine
ظȾsuperinfection
fermentation
official  formula
廯aromatic  compound
䶾ѧradiotoxicology
ҩѧradiopharmaceutics
Ǳ谱non-essential amino  acid
ȥͼҩnondepolarizer
Ӳmolecular  disease
Һmolecular  solution
ѧmolecular  biology
ҩѧmolecular  pharmacology
prosthetic  group
excipients
øcoenzyme
Ӽadditive
side  effect
desiccant;drying  agent
׹ЧӦfirst pass effect of  hepar
receptor
hyperreactivity
individual differences; individual  variation
ҩҩٶdosage regimen or dose  rate
ҩdosing  interval
ҵҩѧindustrial  pharmacy
ۼcovalent  bond
light  quantum
׿broad-spectrum  antibiotic
filtration
anaphylatoxin
ҩﷴӦanaphylactic drug  reaction
superoxide
ȶcontent  uniformity
ϲҩdrug  combination
ϳҩsynthetic  drugs
ϼmixture
nucleotide
Ǻribonucleic acid;  RNA
Ԫtrace  element
ѧchemical  analysis
ѧѧchemical  physics
ѧchemical  disinfection
ѧҩchemotherapy
ҩѧenvironmental  pharmacology
ҩessential  drugs
gene
activator
activation
hormone
ԭprohormone
Զʵacute toxicity  test
Ǵϸcytotoxic  hexitols
dosage;  dose
Ũȵdose or concentration  dependency
dosage  form
°indirect  carcinogenesis
Ъdiscontinuous  sterilization
жalkalosis;alkali-poisoning
Һҩmedical colloidal  solution
ͽglycolysis
׿antagonism
ⶾdetoxication
mediator; transmitter;  medium
psychic  dependence
ҩpowerful  drug
absolute lethal dose;  LD100
Ƭchewable  tablets
antitoxin
antibacterial  spectrum
antibody
Ѫantiserum
ҩresistance to  drugs
ԭantigen
˵gram-equivalent  weight
˵gram-equivalent  number
˷gram-molecule;  gram-mol
˷ӷmolar  fraction
˷gram molecular  weight
˷Ũmolar comcentratin; molal  comcentration
ԭgram-atom
Ƽcontrolled release  preparation
ǻڸҩoral  administration
tachyphylaxis
ɢdiffusion
ɢϵcoefficient of  diffusion
඾anatoxin;toxoid
̴ͣҩۺsteroid withdrawal  syndrome
ۻйcumulative urinary excretion  curves
ۼЧӦadditive  effect
cold-storage
䶳freezing;refrigeration
ҩѧquantum  pharmacology
ٴҩѧclinical  pharmacology
ٴҩѧchlinical  pharmacy
±halogenide
ֲimplants
ͨslow  pathway
Զʵchronic toxicity test; long term toxicity  test
øenzyme
øԭproenzyme
Ƽimmunosuppressant;immuno  inhibitor
ԭimmunogenicity
ǿimmunoenhancement
sensitivity
Ħmole
ĦŨmol fraction  concentration
Ħmolar volume;mole  volume
ĦŨmolarity
Ĭthe Merck  index
ڶendotoxin
ڶԼⶨLimulus Amebocyte Lysate assay for  endotoxin
mesomer
tolerance
ҩdrug  tolerance
Ũconcentration
ƤճĤҩskin and mucocutaneous  administration
ƬӲtablet  hardness
aerogel
ܽaerosol
gas  analysis
aerosol
ǰҩprodrug
עintrathecal  injection
ȫø븨holonzyme and prosthetic  group
˹ϳɿԭartificial  antigen
˹artificial  immunization
ҩѧethnopharmacology
Geneva  nomenclature
ܼsolvent;  dissolvent
ܽdissolution;  dissolving
ܾølysozyme
Ѫhemolysis
solute
ѭtricarboxylic acid  cycle
ɱbactericidal  activity
ɱbactericidal  effect
physical  dependence
񾭶neurotoxin
adrenergic  nerve
adrenergic  receptor
͸ѹosmotic  pressure
growth  curve
ﰷbiogenic  amine
˥biological half  life
ﻯѧbiochemistry
alkaloid
öbioavailability
ͳѧbiometrics;biometry
ҩѧbiopharmacy
Ʒbiological  product
ҩcrude  drugs
ʱҩѧchronopharmacology
ʱchronosusceptability
ʱchronotherapy
ʱЧϵtime-effect  relationship
ʱֵchronaxia;chronaxy
ʱlag  time
֯World Health Organization;  WHO
ɾbacteriophage
ҩastringent
ҩchiral  drug
׹ЧӦfirst-pass  effect
receptor
弤receptor  stimulant
׿receptor  antagonist
˫ädouble-blind  technique
ˮ⣨ãhydrolysis
gluconeogenesis
body surface  area
Ũvolume by volume  concentration
Һbody  fluid
Һhumoral  immunity
Ȼnatural  antibody
Ȼԭnatural  antigen
Ȼnatural  immunity
Ȼҩcrude drugs; natural  drugs
ͬλisotope
ͻmutation
phagocytosis
ⶾexotoxin
raceme
ȫԭcomplete  antigen
ˮaqua regia; nitrohydrochloric  acid
΢ømicrosomal  enzyme
΢Ԫtrace  element
̬ѪҩŨsteady state plasma  concentration
ҩѧphysical  pharmaceutics
뷨inhalation
ʳabsorption rate  constant
ϸcellular  immunity
Ծҩrestrictive  holagogue
adenosine  phosphate
Ըҩrelative dosage  interval
additive effect;  addition
иҩtargetable drug  delivery
ʳelimination rate  constant
Чpotency
Ч۵λpotency  unit
Чǿpotency
ЧӦeffect
ЧӦeffector
ЧӦeffector
Эcipher  prescription
Эͬsynergism
˷excitability
sequential  design
Һsuspension
ѡselectivity
Ѫڸҩintravascular  administration
Ѫҩextravascular  administration
Ѫplasma
ѪҺplasma  substitute
Ѫ׽plasma protein binding  ratio
Ѫblood-cerebral  barrier
Ѫserum
Ѫblood volume  expander
ѪҩŨblood  concentration
ѪҺblood  coagulation
ѪҺƷblood  products
Ǽжsubacute intoxication;subacute  poisoning
жnitrite  poisoning
Ĥocular  inserts
ҩŨpeak concentration of  drug
ҩʱpeak time of  drug
ҩЧpharmaceutical  equivalence
ҩѧpharmaceutics
ҩѧpharmacology
ҩdrug sensitive  test
ҩƷallotted date of drug quality ensuring by  manufacturer
ҩƷdrug administration  law
ҩƷdrug batch  number
ҩƷʹlimit date of using a drug after its  production
ҩƷЧexpiry date; date of  expiration
ҩƷ׼drug  standard
ҩʱsemi-logarithmic curve of  drug-time
ҩʱdrug-time  curve
ҩлdrug  metabolism
ҩлødrug metablic  enzyme
ҩڹintracorporal process of  drugs
ҩﶯѧģpharmacokinetics  model
ҩﷴӦdrug  reaction
ҩֲdrug  distribution
ҩpharmaceutical  analysis
ҩﻯѧpharmaceutical  chemistry
ҩйdrug  excretion
ҩdrug  absorption
ҩ໥drug  interaction
ҩdrug  elimination
ҩdrug  accumulation
ҩѧpharmacology; materia  medica
ҩŴѧpharmacogenetics
ҩЧѧpharmacodynamics
ҩԴԼdrug-induced  diseases
acetylcholine
øacetylcholinesterase
칹øisomerase
־bacteriostatic  activity
־bactriostasis
Ӫnutrient
Ӳplaster
Ч˥effective  halt
Чeffective  rate
ЧŨeffective  concentration
dextrose
dextrorotatory  form
мthreshold  dose
carrier
߰saponins
֬liposome
ֱҩrectal  administration
ֱlinear  correlation
ֽƬoral medicaed soluble  paper
Ƽpreparation
Ƽѧtechnology of  pharmaceutics
ҩѧpharmaceutical  chemistry
ƵЧֵtherapeutic  equivalence
therapeutic  dose
ҩٲtherapeutic drug monitoring;  TDM
ָtherapeutic index  TI
therapeutic  action
°ʵcarcinogenic  test
°carcinogen
»teratogenic  test
»teratogen
sensitization  test
sensitization
fatal dose; lethal  dose
жintoxication;  poisoning
л񹲺͹ҩƷ׼Drug Standard of Ministry of Public Health of the People''s Republic of  China
мintermediate
˼filter  aid
ܼcomplex  solubilizer
suspending  agent
autoimmunity
鰷histamine
ܼmaximal tolerable dose;  LDO
ümaxial noneffective dose;  EDO
Сleast significant  difference
СЧminimal effective  dose
Сminimal lethal  dose;MLD
levulose
levorotatory  form
adjuvant
